Bolt BiotherapeuticsBOLT
13F holders, Q2 2025 (June 30)25holders
1famous investor
$5.74avg. 13F price*
At the end of Q2 2025, 25 institutions reported holding Bolt Biotherapeutics Inc. (BOLT) in their 13F filings. The largest holders were Vivo Capital, LLC ($986K), Tang Capital Management LLC ($963K) and Sofinnova Investments, Inc. ($795K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Bolt Biotherapeutics Inc.
- CUSIP
- 097702203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3K |
| Exits | 0 | $0 |
Ownership 25 holders
| Vivo Capital, LLC | 0.10% | No change | 176,064 | $986K |
| Tang Capital Management LLC | 0.05% | Reduce -12.5% | 166,879 | $963K |
| Sofinnova Investments, Inc. | 0.05% | No change | 137,721 | $795K |
| Pivotal bioVenture Partners Investment Advisor LLC | 0.34% | No change | 94,573 | $546K |
| Vanguard Group Inc. | 0.00% | No change | 58,484 | $341K |
| Nan Fung Group Holdings Ltd | 0.53% | No change | 58,347 | $337K |
| Samsara Biocapital, LLC | 0.06% | No change | 52,456 | $303K |
| Board of Trustees of The Leland Stanford Junior University | 0.02% | No change | 35,978 | $208K |
| Pfizer Inc | 0.03% | No change | 31,305 | $181K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.2% | 18,533 | $108K |
| Renaissance Technologies | 0.00% | Add +16.7% | 18,325 | $106K |
| Squarepoint Ops LLC | 0.00% | Add +195.3% | 12,388 | $72K |
| ADAR1 Capital Management, LLC | 0.01% | Reduce -11.6% | 10,823 | $62K |
| BlackRock, Inc. | 0.00% | Reduce -21.5% | 10,550 | $61K |
| Morgan Stanley | 0.00% | Add +516.3% | 3,579 | $21K |
| NewEdge Advisors, LLC | 0.00% | New | 483 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -9.1% | 395 | $2K |
| Bank of America Corp. | 0.00% | Add +0.2% | 282 | $2K |
| UBS Group AG | 0.00% | Reduce -96.7% | 183 | $1K |
| FMR LLC | 0.00% | Reduce -70.1% | 121 | $705 |
| JPMorgan Chase & Co. | 0.00% | Reduce -5.1% | 43 | $251 |
| SBI Securities Co., Ltd. | 0.00% | No change | 10 | $58 |
| Barclays PLC | 0.00% | Reduce -13.7% | 6 | $35 |
| Salem Investment Counselors Inc. | 0.00% | No change | 2 | $12 |
| Danske Bank A/S | 0.00% | New | 1 | $6 |
"% of holder's portfolio" is BOLT's weight in each manager's 13F, not the share of Bolt Biotherapeutics Inc. the manager owns.